Abstract
Cisplatin conjugated onto macromolecules or loaded in micelles can be preferentially delivered to tumors to minimize its toxicity to healthy tissues and increase its drug efficacy. Herein, we report cisplatin-containing nanogels possibly useful for targeted delivery of cisplatin. Carboxylic acid-functionalized poly(β -aminoester)graft-poly(ethylene glycol) copolymers were synthesized by cocondensation polymerization of piperazine with 2,2-bis(acryloxymethyl)propionic acid, PEG 2,2-bis(acryloxymethyl)propionate macromonomer (mPEG). The graft copolymers formed 100-200 nm nanogels with low size-distribution by the complexation of their carboxylic groups with cisplatin. The nanogels were negatively charged and had a PEG outer layer. Thus, they had "stealth properties" suitable for in vivo applications. The nanogels had significantly lower in vitro cytotoxicity to SKOV-3 ovarian cancer cells than free cisplatin, but similar anticancer activity toward SKOV-3 tumors xenografted to immunocompromised mice. Copyright © Informa Healthcare.
Author supplied keywords
Cite
CITATION STYLE
Jin, W., Xu, P., Zhan, Y., Shen, Y., Van Kirk, E. A., Alexander, B., … Isaak, D. D. (2007). Degradable cisplatin-releasing core-shell nanogels from zwitterionic poly(β -aminoester)-graft-PEG for cancer chemotherapy. Drug Delivery, 14(5), 279–286. https://doi.org/10.1080/10717540601036856
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.